RA is attributed to the interaction of pathological T cells and synovial cells, which promotes the expression of receptor activator of NF-κB ligand (RANKL) on synovial fibroblasts resulting in osteoclast differentiation, and then, bone resorption [5,6,7]. This evidence concerns the gene TNFSF11 and rheumatoid arthritis.